Correction to: Crit Care (2021) 25:177. https://doi.org/10.1186/s13054-021-03588-4

Following publication of the original article [1], the authors identified an error in the Abstract and Results section. The correct numbers and text are given hereafter.

Abstract


VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 group (adjusted HR 1.65 (95% CI 1.11–2.46), p = 0.013), but not in influenza (1.74 (0.99–3.06), p = 0.052), or no viral infection groups (1.13 (0.68–1.86), p = 0.63).

Results


Primary and secondary outcomes: VAP was associated with higher risk for 28-day mortality in in SARS-CoV-2 group, but not in the two other groups (Fig. 2A).


All the changes that were requested are implemented in this correction and the original article [1] has been corrected.